Actimis Pharmaceuticals

Actimis Pharmaceuticals, Inc. is a start-up biopharmaceutical company dedicated to developing small molecule therapeutics aimed at treating respiratory, inflammatory, and autoimmune disorders. Established as a spin-off from Bayer Healthcare AG's research portfolio, the company was founded by Dr. Kevin Bacon, who previously served as Vice President and Global Head of Respiratory Diseases research at Bayer Yakuhin Ltd. Actimis focuses on creating effective treatments for conditions such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease, and rheumatoid arthritis, thereby providing physicians with innovative options to manage these challenging diseases. The company has attracted venture financing from notable investors, positioning itself to advance its therapeutic pipeline.